SANSA HSAT

by Huxley Medical  · Based in United States → — A revolution in home sleep apnea testing.
Otolaryngology (ENT) Pulmonology Sleep Medicine

Not disclosed
Regulatory Status Disclosed

Overview

SANSA HSAT by Huxley Medical is an FDA-cleared, chest-worn diagnostic patch designed to streamline the evaluation of sleep-related breathing disorders, including Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), in adults. Unlike traditional home sleep apnea tests, SANSA HSAT offers an app-free workflow, utilizing cellular data upload to transmit physiological data directly to physicians, eliminating the need for Bluetooth pairing or smartphone applications. The device integrates a reflective photoplethysmography (PPG) sensor, a single-lead electrocardiogram (ECG) sensor, and a 3-axis accelerometer to measure nine physiological data channels: blood oxygen saturation (SpO2), heart rate, respiratory effort, chest movement, ECG, body position, actigraphy, snoring, and sleep/wake staging. It employs AI-powered auto-scoring to generate automated, customizable reports on the Huxley HUB™ software portal, aiding physicians in diagnosis and treatment planning. SANSA HSAT is designed to enhance practice efficiency, reduce patient calls, and eliminate testing backlogs by offering scalable, direct-to-patient test delivery and 24/7 live support.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Chest-worn diagnostic patch for home use
  • App-free workflow with cellular data upload
  • AI-powered auto-scoring for automated reports
  • Measures 9 physiological data channels (SpO2, Heart Rate, Respiratory Effort, Chest Movement, ECG, Body Position, Actigraphy, Snoring, Sleep/Wake Staging)
  • FDA-cleared for Obstructive and Central Sleep Apnea detection
  • Eliminates wires, belts, hoses, or additional attachments
  • Direct-to-patient test delivery
  • 24/7 live support
  • Customizable report templates

Use Cases

  • Diagnosis of Obstructive Sleep Apnea (OSA)
  • Diagnosis of Central Sleep Apnea (CSA)
  • Streamlining home sleep apnea testing for healthcare providers
  • Reducing patient calls and clinic visits for sleep disorder diagnosis
  • Enriching cardiosleep management with comprehensive data
  • Assessing cardiac rhythm with ECG during sleep testing

What Physicians Need to Know

EEG Interpretation AI
SANSA HSAT utilizes AI/ML components within its cloud-based algorithm to compute time-series data for clinician review, including sleep staging (Sleep/Wake) and REM/NREM classification. It measures physiological signals such as actigraphy to infer sleep stages, demonstrating an accuracy of 87.2% for epoch-level sleep/wake classification against polysomnography (PSG).
Triage Prioritization Speed
The cellular data upload capability of SANSA HSAT eliminates the need for Bluetooth pairing or smartphone apps, allowing physicians and technicians to receive data in near real-time once a test is complete. This streamlines workflows and accelerates the time to care for sleep apnea and cardiac insights.
Mobile Notification System
SANSA HSAT features built-in cellular data upload, making it an app-free, hands-free, and wire-free solution for transmitting test data. Recorded data is uploaded to a cloud-based software portal (Huxley HUBu2122) where physiological tracings are made available for review and event editing by a qualified healthcare professional.
Physician Tip

SANSA HSAT offers a streamlined approach to diagnosing obstructive sleep apnea (OSA) and detecting cardiac arrhythmias from home, integrating cardiosleep assessments into a single, easy-to-use chest patch. Its app-free cellular data upload simplifies the patient experience and provides rapid access to automated reports and physiological tracings for efficient review and diagnosis. This can significantly reduce testing backlogs and enhance diagnostic capabilities, particularly for patients with comorbid cardiac conditions. The device's FDA clearance and validation against gold-standard polysomnography ensure reliable diagnostic performance across diverse populations.

The SANSA HSAT system operates on Huxley HUBu2122, a cloud-native platform designed to modernize workflows. This platform provides a secure, HIPAA-compliant, web-based user interface for seamless patient workflow management. Data is accessible anywhere, anytime, with real-time re-scoring capabilities and customizable report templates. Sleep and ECG reports are delivered directly to respective specialists post-review and interpretation.

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Not disclosed — Not disclosed
DeploymentDevice-based, with data uploaded to a cloud-based software portal (Huxley HUB™) for physician review.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

SANSA HSAT has received multiple FDA 510(k) clearances. The latest clearance (K252497, December 10, 2025) added the ability to classify between Obstructive and Central Sleep Apnea events using an AI/ML classifier. Previous clearances include cellular data upload (February 5, 2025) and initial clearance for sleep apnea testing (July 2024).

Integrations
EHR Not specified
Specialties Otolaryngology (ENT), Pulmonology, Sleep Medicine

What the Web Says

The SANSA HSAT by Huxley Medical is a wearable home sleep apnea test designed to evaluate sleep-related breathing disorders in adults. It's a prescription-only device intended for use in both clinical and home settings under the direction of a healthcare professional. The device utilizes a single chest-worn patch with PPG, ECG, and accelerometer sensors, and its data is analyzed by a cloud-based AI/ML algorithm to provide clinicians with time-series data and summary metrics.

Overall: Positive

Strengths

  • Comparable accuracy to in-laboratory polysomnography (PSG) for detecting moderate-to-severe OSA.
  • Simplified application and patient training due to a single point of contact on the chest, eliminating multiple belts, wires, and tubes.
  • Familiar Holter monitor-like design may encourage interdisciplinary collaborations with cardiologists and primary care physicians.
  • High sensitivity across all OSA severity categories and reliable performance across all skin tones.
  • Captures nine physiological channels without failure-prone wires, belts, finger probes, or nasal cannulas.
  • Data uploads automatically over integrated cellular, removing the need for smartphones, Bluetooth, or pairing.

Limitations

  • Specificity decreased at lower AHI cutoffs, consistent with other home sleep testing devices.
  • The ECG channel is for reference only and not for automated ECG analysis or pacemaker analysis.
  • Requires review and event editing by a qualified healthcare professional.
  • Prescription-use only.

Based on reviews from: Medical Management of Obstructive Sleep Apnea Syndrome, Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announces | Patient Care Online, July 15, 2024 Huxley Medical Grace Powers Founder - accessdata.fda.gov, Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome - Blue Cross and Blue Shield of Kansas, October 29, 2025 Huxley Medical Grace Powers Founder - accessdata.fda.gov, Huxley SANSA Home Sleep Apnea Test (1000-00) (K240285) u2014 FDA 510(k) | Innolitics, SANSA Sleep Apnea Diagnostic Patch Cleared By FDA - SleepWorld Magazine, Peer-Reviewed Study Validates Accuracy of SANSA Home Sleep Apnea Test, January 28, 2025 Huxley Medical u2105 Grace Powers Founder - accessdata.fda.gov, Sleep apnea test | SANSA by Huxley

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SANSA HSAT

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Patient Care Online
Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announces
Huxley Medical announced that a clinical validation study for its SANSA home sleep apnea test has been published in Frontiers in Neurology, demonstrating comparable performance to in-laboratory polysomnography. The study of 340 participants showed SANSA achieved 88% sensitivity and 87% specificity for detecting moderate-to-severe OSA.
2025-06
PR Newswire
Huxley Medical's SANSA Receives Diagnostic ECG Clearance from FDA, Paving Way for First Solution to Systematically Detect Arrhythmias During Home Sleep Testing
Huxley Medical, Inc. announced that its SANSA home sleep apnea test received FDA clearance to be used as a diagnostic ECG monitor, making it the first home sleep apnea test capable of offering diagnostic insight into cardiac arrhythmias from a single chest-worn patch. This clearance positions SANSA at the intersection of cardiology and sleep medicine.
2025-12
PR Newswire
Peer-Reviewed Study Validates Accuracy of SANSA Home Sleep Apnea Test
Huxley Medical announced the publication of a clinical validation study for its SANSA home sleep apnea test in Frontiers in Neurology, confirming its comparable performance to in-lab polysomnography for obstructive sleep apnea diagnosis. The multicenter trial included 340 participants across seven U.S. clinical sites.
2025-06
ATDC
U.S. Food and Drug Administration Gives Huxley Medical 510(k) Clearance for SANSA Home Sleep Apnea Test
Huxley Medical received 510(k) clearance from the FDA for its chest-worn, sleep apnea diagnostic patch, SANSA. This device is a first-of-its-kind, at-home, single-point-of-skin-contact diagnostic that measures eight physiological channels and provides an EKG reference channel.
2024-08
BioSpace
Huxley Medical Announces FDA Clearance for Cellular-Enabled SANSA Home Sleep Apnea Test
Huxley Medical announced FDA clearance for its SANSA home sleep apnea test to use cellular data upload capabilities, eliminating the need for Bluetooth pairing or smartphone apps. This advancement simplifies the diagnostic process for patients and providers.
2025-02
FirstWord HealthTech
Huxley Medical Announces Commercial Launch of FDA-Cleared Central Sleep Apnea Detection and Appointment of Medical Director of Sleep Medicine
Huxley Medical, Inc. announced FDA 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA home sleep apnea test. The company also appointed Nancy A. Collop, MD, as Medical Director of Sleep Medicine.
2025-12
Frontiers in Neurology / PMC - NIH
Polysomnography validation of SANSA to detect obstructive sleep apnea
This prospective multicenter validation study evaluated the SANSA home sleep apnea test, demonstrating robust diagnostic performance for OSA detection and sleep measurement compared to polysomnography. The study highlights SANSA's ease of use and multi-diagnostic potential for OSA and cardiac arrhythmias.
2025-06
BioSpace
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
Huxley Medical introduced SANSA GO, a point-of-care enrollment model, and hypoxic burden, an additional cardiovascular strain measure, to its SANSA platform. These additions build on SANSA's existing FDA clearances for assessing ECG, obstructive sleep apnea, and central sleep apnea.
2026-06

Videos

Product demos, reviews, and walkthroughs for SANSA HSAT.

View all on YouTube

Frequently Asked Questions

SANSA HSAT is a chest-worn patch that utilizes a reflective photoplethysmography (PPG) sensor, a single-lead electrocardiogram (ECG) sensor, and a 3-axis accelerometer to collect physiological signals. These signals, including blood oxygen saturation, heart rate, respiratory effort, snoring, and sleep staging, are processed by a cloud-based AI/ML algorithm to aid in the evaluation of sleep-related breathing disorders.
Physicians prescribe the SANSA device, which is shipped directly to the patient for at-home use, eliminating the need for complex setups or smartphone apps due to its cellular data upload capability. The AI-powered algorithm generates an automated report on the Huxley HUBu2122 portal, allowing physicians to review data, finalize diagnoses, and identify potential cardiac arrhythmias for integrated cardiosleep management.
SANSA HSAT is FDA-cleared for diagnosing obstructive sleep apnea and has received clearance for use as a diagnostic ECG monitor to detect cardiac arrhythmias. As a prescription-only medical device handling patient health information, it is designed to comply with relevant data privacy regulations like HIPAA, and its cloud-based AI/ML algorithms operate under FDA oversight.
SANSA HSAT distinguishes itself as a hands-free, wire-free, and app-free chest-worn patch with direct cellular data upload, simplifying the patient experience. It uniquely combines comprehensive sleep apnea diagnostics with diagnostic ECG monitoring for cardiac arrhythmias, offering a multi-diagnostic approach not typically found in other HSATs.
While specific pricing details are not publicly disclosed, Huxley Medical offers a 'SANSA Expressu2122' program designed to streamline throughput and reduce backlogs, suggesting a service-oriented model that may involve direct-to-patient shipping and automated reporting. Practices can customize workflow services, potentially influencing the overall cost structure.
While SANSA HSAT has demonstrated robust diagnostic performance, like other HSATs, it may have limitations in complex conditions such as hypoventilation or severe chronic obstructive pulmonary disease (COPD). It is intended for adults aged 22 years and older and is not indicated for patients with certain pre-existing cardiac conditions or those with significant non-respiratory sleep disorders.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Huxley Medical

Huxley SANSA Home Sleep Apnea Test (1000-00)
Huxley Medical
Cardiology AI
Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.